Biotech Investors & VC Firms in Asia-Pacific

571 firms in this list, with a median first check of $650K. 110 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
Shinsei Capital Partners	Tokyo	JP	Pre-Seed–Late Stage	—	+ Add to CRM
Gaorong Capital 5 people	Beijing	CN	Seed–Series B	—	+ Add to CRM
Trans-Pacific Technology Fund 8 people	Taipei	TW	Seed–Late Stage	—	+ Add to CRM
E15 1 person	Hong Kong	HK	Pre-Seed–Late Stage	—	+ Add to CRM
Shinhan Venture Investment 1 person	Seoul	KR	Series A–Growth	$2.2M – $45M	+ Add to CRM
Stonebridge Ventures 3 people	Seoul	KR	Seed–Late Stage	$743K – $33M	+ Add to CRM
TriWise Capital 1 person · Leads rounds	Shenzhen	CN	Pre-Seed–Late Stage	—	+ Add to CRM
YFY Biotech Management Company 1 person	Taipei	TW	Seed–Series B	—	+ Add to CRM
Virtus Inspire Ventures 7 people	—	HK	Seed–Series A	—	+ Add to CRM
East West Capital Limited 1 person	Sydney	AU	Pre-Seed–Late Stage	—	+ Add to CRM
Hokkaido Venture Capital, Inc. 1 person	Sapporo	JP	Pre-Seed–Late Stage	—	+ Add to CRM
Panda Capital 1 person	—	CN	Pre-Seed–Late Stage	—	+ Add to CRM
UniQuest Extension Fund (UEF) 1 person	Brisbane	AU	Pre-Seed–Seed	—	+ Add to CRM
WERU Investment Co. Ltd.	Tokyo	JP	Pre-Seed–Growth	—	+ Add to CRM
Zhongguancun Development Group Leads rounds	Beijing	CN	Pre-Seed–Growth	—	+ Add to CRM
ABICO Asia Capital Corporation 1 person	Taipei	TW	Seed–Late Stage	—	+ Add to CRM
CCV Capital 1 person · Follows rounds	Beijing	CN	Seed–Series B	—	+ Add to CRM
Haibang Capital 1 person	Hangzhou	CN	Pre-Seed–Late Stage	—	+ Add to CRM
Lotus Lake Ventures 7 people	Beijing	CN	Seed–Series A	—	+ Add to CRM
Fosun Pharma	Shanghai	CN	—	—	+ Add to CRM
Hefei High-tech VC Follows rounds	Hefei	CN	Seed–Series C	—	+ Add to CRM
Ausvic Capital	Hong Kong	HK	Pre-Seed–Series A	—	+ Add to CRM
BioTrack Capital 6 people	Grand Cayman	CN	Seed–Late Stage	—	+ Add to CRM
Mankind Pharma	New Delhi	IN	Series A	—	+ Add to CRM